Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

The Impact of Healthcare-Associated Infections in Patients Undergoing Oncological Microvascular Head and Neck Reconstruction: A Prospective Multicentre Study

dc.contributor.authorRamos Zayas, Ana
dc.contributor.authorLópez Medrano, Francisco
dc.contributor.authorUrquiza Fornovi, Irene
dc.contributor.authorZubillaga Rodríguez, Ignacio
dc.contributor.authorGutiérrez, Ramón
dc.contributor.authorSánchez Aniceto, Gregorio
dc.contributor.authorAcero, Julio
dc.contributor.authorAlmeida, Fernando
dc.contributor.authorGaldona, Ana
dc.contributor.authorMorán, María José
dc.contributor.authorPampin, Marta
dc.contributor.authorCebrián, José Luis
dc.date.accessioned2023-06-17T08:23:05Z
dc.date.available2023-06-17T08:23:05Z
dc.date.issued2021-04-27
dc.description.abstract(1) Background: Healthcare-associated infections (HAIs) after head and neck free-flap reconstruction are a common postoperative complication. Risk factors for HAIs in this context and their consequences have not been adequately described. (2) Methods: Ongoing prospective multicentre study between 02/2019 and 12/2020. Demographic characteristics and outcomes were analysed, focusing on infections. (3) Results: Forty out of 65 patients (61.54%) suffered HAIs (surgical site infection: 52.18%, nosocomial pneumonia: 23.20%, bloodstream infection: 13% and urinary tract infection: 5.80%). Methicillin-resistant Staphylococcus aureus (MRSA) and resistant Pseudomonas aeruginosa, Klebsiella pneumoniae and Enterobacter cloacae were the most frequently implicated. The significant risk factors for infection were: previous radiotherapy (Odds ratio (OR): 5.42; 95% confidence interval (CI), 1.39–21.10), anaemia (OR: 8.00; 95% CI, 0.96–66.95), salvage surgery (eight out of eight patients), tracheostomy (OR: 2.86; 95% CI, 1.01–8.14), surgery duration (OR: 1.01; 95% CI, 1.00–1.02), microvascular reoperation <72 h (eight/eight) and flap loss (eight/eight). The major surgical complications were: a need to reoperate (OR: 6.89; 95% CI, 1.42–33.51), prolonged hospital admission (OR: 1.16; 95% CI, 1.06–1.27) and delay in the initiation of postoperative radiotherapy (OR: 9.07; 95% CI, 1.72–47.67). The sixth month mortality rate in patients with HAIs was 7.69% vs. 0% in patients without HAIs (p = 0.50). (4) Conclusions: HAIs were common after this type of surgery, many of them caused by resistant microorganisms. Some modifiable risk factors were identified. Infections played a role in cancer prognosis by delaying adjuvant therapy.
dc.description.departmentDepto. de Medicina
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.statuspub
dc.eprint.idhttps://eprints.ucm.es/id/eprint/70924
dc.identifier.doi10.3390/cancers13092109
dc.identifier.issn2072-6694
dc.identifier.officialurlhttps://doi.org/10.3390/cancers13092109
dc.identifier.relatedurlhttps://www.mdpi.com/2072-6694/13/9/2109/htm
dc.identifier.urihttps://hdl.handle.net/20.500.14352/6888
dc.issue.number9
dc.journal.titleCancers
dc.language.isoeng
dc.page.initial2109
dc.publisherMPDI
dc.rightsAtribución 3.0 España
dc.rights.accessRightsopen access
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/es/
dc.subject.keywordhead and neck surgery
dc.subject.keywordreconstructive surgery
dc.subject.keywordfree flaps
dc.subject.keywordhealthcare-associated infections
dc.subject.keywordsurgical site infection
dc.subject.keywordantibiotic prophylaxis
dc.subject.keywordresistant microorganisms
dc.subject.keywordosteoradionecrosis
dc.subject.ucmInmunología
dc.subject.ucmOncología
dc.subject.unesco2412 Inmunología
dc.subject.unesco3201.01 Oncología
dc.titleThe Impact of Healthcare-Associated Infections in Patients Undergoing Oncological Microvascular Head and Neck Reconstruction: A Prospective Multicentre Study
dc.typejournal article
dc.volume.number13
dspace.entity.typePublication
relation.isAuthorOfPublication0c67752b-2d61-4f29-840f-5cd431c36093
relation.isAuthorOfPublicatione6f77848-1888-4ca8-9b51-038ec6bc92e8
relation.isAuthorOfPublication246f9d82-3ae3-404f-83b4-ccc1015f1ad4
relation.isAuthorOfPublication.latestForDiscovery0c67752b-2d61-4f29-840f-5cd431c36093

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
cancers-13-02109-v2.pdf
Size:
629.65 KB
Format:
Adobe Portable Document Format

Collections